HuGE Literature Finder
Records
1
-
30
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| Genomic landscape of ground glass opacities (GGOs) in East Asians. Journal of thoracic disease 2021 Apr 13 (4): 2393-2403. Cao Peng, Hu Shan, Kong Kangle, Han Peng, Yue Jiaqi, Deng Yu, Zhao Bo, Li F |
| Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis. Medicine 2021 Mar 100 (10): e19713. Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa |
| The utility of the Ion Torrent PGM next generation sequencing for analysis of the most commonly mutated genes among patients with colorectal cancer in India. Indian journal of cancer 2021 Mar . Mehra Simmi, Tiwari Aseem Kumar, Mehta Swati Pabbi, Sachdev Ritesh, Rajvanshi Chhavi, Chauhan Rajni, Saini Abhishek, Vaid Ash |
| [Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246. Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch |
| Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study. Thrombosis research 2019 Dec 186 36-41. Dou Feifei, Zhang Yuan, Yi Jiawen, Zhu Min, Zhang Shu, Zhang Di, Zhang Yuh |
| KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy. Cancers 2019 Oct 11 (10): . Ghimessy Aron Kristof, Gellert Aron, Schlegl Erzsebet, Hegedus Balazs, Raso Erzsebet, Barbai Tamas, Timar Jozsef, Ostoros Gyula, Megyesfalvi Zsolt, Gieszer Balazs, Moldvay Judit, Renyi-Vamos Ferenc, Lohinai Zoltan, Hoda Mir Alireza, Klikovits Thomas, Klepetko Walter, Laszlo Viktoria, Dome Bala |
| Positive Correlation Between Somatic Mutations in RAS Gene and Colorectal Cancer in Telangana Population: Hospital-Based Study in a Cosmopolitan City. Applied biochemistry and biotechnology 2019 Sep . Goud Kalal Iravathy, Matam Kavitha, Madasu Adi Mahalakshmi, Ali Khan Imr |
| Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas. International journal of clinical oncology 2019 May . Liang Xiaohong, Li Qing, Xu Bin, Hu Song, Wang Qianyun, Li Yan, Zong Yun, Zhang Sujuan, Li Cho |
| Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid-based cytology. Diagnostic cytopathology 2019 Feb . Tanaka Ryota, Sakamoto Norihiko, Suzuki Hitomi, Tachibana Keisei, Ohtsuka Kouki, Kishimoto Koji, Fujiwara Masachika, Kamma Hiroshi, Shibahara Junji, Kondo Haruhi |
| Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma. Journal of Cancer 2019 10 (1): 61-71. Li Pupu, Gao Qiongqiong, Jiang Xiangli, Zhan Zhongli, Yan Qingna, Li Zhaona, Huang Ch |
| The Frequency of EGFR and KRAS Mutations in the Turkish Population with Non-small Cell Lung Cancer and their Response to Erlotinib Therapy. Balkan journal of medical genetics : BJMG 2018 Dec 21 (2): 21-26. A Demiray, A Yaren, N Karagenç, F Bir, Ag Demiray, Er Karagür, O Tokgün, L Elmas, H Ak |
| Detection of RAS and RAS-associated alterations in primary lung adenocarcinomas. A correlation between molecular findings and tumor characteristics. Human pathology 2018 Sep . Shaukat Irfan, Kern Jason J, Höti Naseruddin, Zhang H, Li Jason, Zheng Gang, Askin Frederic, Gabrielson Edward, Li Qing K |
| Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection Rates. Digestion 2018 Aug 98 (4): 263-269. Koch Christine, Schmidt Niklas, Winkelmann Ria, Eichler Katrin, Pession Ursula, Bechstein Wolf Otto, Zeuzem Stefan, Waidmann Oliver, Trojan Jö |
| Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma. Oncology letters 2018 Aug 16 (2): 2105-2112. Yuan Xiao-Han, Yang Jie, Wang Xin-Yue, Zhang Xiao-Ling, Qin Ting-Ting, Li K |
| Survival analysis in Caucasian pulmonary adenocarcinoma patients based on differential targets between Caucasian and Asian population. Saudi journal of biological sciences 2018 Jul 25 (5): 1003-1006. Zhu Zheng, Liang Zhigang, Tong Jichun, Mao Xiaoliang, Yin Yajun, Manor Lydia C, Shen Zhen |
| Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study. Virchows Archiv : an international journal of pathology 2018 Apr 472 (4): 581-588. Schwegler Christine, Kaufmann Dinu, Pfeiffer David, Aebi Stefan, Diebold Joachim, Gautschi Oliv |
| Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations. Oncotarget 2018 Apr 9 (28): 19891-19899. Somaiah Neeta, Beird Hannah C, Barbo Andrea, Song Juhee, Mills Shaw Kenna R, Wang Wei-Lien, Eterovic Karina, Chen Ken, Lazar Alexander, Conley Anthony P, Ravi Vinod, Hwu Patrick, Futreal Andrew, Simon George, Meric-Bernstam Funda, Hong Dav |
| Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas. Clinical radiology 2018 Feb . Lv J, Zhang H, Ma J, Ma Y, Gao G, Song Z, Yang |
| Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
| Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid. Clinical chemistry and laboratory medicine 2018 04 56 (5): 748-753. Frankel Diane, Nanni-Metellus Isabelle, Robaglia-Schlupp Andrée, Tomasini Pascale, Guinde Julien, Barlesi Fabrice, Astoul Philippe, Ouafik L'Houcine, Amatore Florent, Secq Véronique, Kaspi Elise, Roll Patri |
| Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer. Clinical colorectal cancer 2018 09 17 (3): 206-214. Kim Tae Won, Elme Anneli, Park Joon Oh, Udrea Anghel Adrian, Kim Sun Young, Ahn Joong Bae, Valencia Ricardo Villalobos, Krishnan Srinivasan, Manojlovic Nebojsa, Guan Xuesong, Lofton-Day Catherine, Jung A Scott, Vrdoljak Edua |
| MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy. Clinical lung cancer 2018 07 19 (4): e441-e463. Reis Henning, Metzenmacher Martin, Goetz Moritz, Savvidou Nikoleta, Darwiche Kaid, Aigner Clemens, Herold Thomas, Eberhardt Wilfried E, Skiba Charlotte, Hense Jörg, Virchow Isabel, Westerwick Daniela, Bogner Simon, Ting Saskia, Kasper Stefan, Stuschke Martin, Nensa Felix, Herrmann Ken, Hager Thomas, Schmid Kurt W, Schuler Martin, Wiesweg Marc |
| Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma. Internal medicine journal 2018 01 48 (1): 37-44. Tan Lavinia, Alexander Marliese, Officer Ann, MacManus Michael, Mileshkin Linda, Jennens Ross, Herath Dishan, de Boer Richard, Fox Stephen B, Ball David, Solomon Benjam |
| Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens. Medicine 2017 Sep 96 (39): e8153. Zhao Long, Huang Shanshan, Liu Jinjun, Zhao Juan, Li Qiang, Wang Huo-Qia |
| Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative F FDG-PET/CT metrics. Oncotarget 2017 (32): 52792-52801. Minamimoto Ryogo, Jamali Mehran, Gevaert Olivier, Echegaray Sebastian, Khuong Amanda, Hoang Chuong D, Shrager Joseph B, Plevritis Sylvia K, Rubin Daniel L, Leung Ann N, Napel Sandy, Quon Andr |
| A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes. Journal of thoracic disease 2017 Aug 9 (8): 2560-2571. Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: